-
Thematic Analysis
NewArtificial Intelligence – Executive Briefing (Third Edition) – Thematic Intelligence
Artificial Intelligence (AI) Thematic Report Overview The AI market is forecast to grow at a CAGR of more than 38% between 2023 and 2030. The recent success of OpenAI’s ChatGPT has influenced most of the tech giants to realign their AI priorities. While some of them have been already working on the underlying technology i.e., generative AI (GenAI), they are now rushing for an edge in the new AI era with a flurry of initiatives. The competitive landscape is evolving...
-
Thematic Analysis
NewTelecom Infrastructure Sector Scorecard, Q1 2024 Update – Thematic Intelligence
The thematic screen of GlobalData’s telecom infrastructure sector scorecard is led by global vendors that score well in the themes related to cloud computing (e.g., programmable infrastructure, edge computing, private networks), 5G, and artificial intelligence (AI). The leaders include US network vendor Cisco, European radio access network (RAN) specialists Nokia and Ericsson, and innovative new entrants such as Mavenir and Rakuten, which is reaping the benefits of acquiring Open RAN vendor Altiostar.
-
Product Insights
NewLikelihood of Approval Analysis for Neisseriaceae Infections
Overview How likely is it that the drugs in Neisseriaceae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseriaceae Infections Overview The Neisseriaceae family encompasses a group of bacteria, including...
-
Thematic Analysis
NewGeneric Drugs – Physician Perspective – Thematic Intelligence
Reasons to buy the ‘Generic Drugs – Physician Perspective’ thematic intelligence report: Assess healthcare professionals’ attitudes towards generic drugs prescription. Better understand the barriers to the production and uptake of generic medicines. Capture physicians’ opinions on generics substitution. Better understand patients’ preferences. Assess past and future generics uptake. Gain a better understanding of cost consideration when prescribing drugs. Explore the differences across markets. How is our ‘Generic Drugs – Physician Perspective’ report unique from other reports in the market? This...
-
Sector Analysis
NewUnited Kingdom (UK) Easter Market Analysis, Trends, Consumer Attitudes and Buying Dynamics, 2024 Update
United Kingdom (UK) Easter Market Report Overview The proportion of consumers agreeing that they did more Easter activities this year versus last year waned in 2024, as consumers opted for other activities during the long weekend. However, among those consumers with children, participation remained high, with over 62% of consumers with their youngest child being between 0-4 years of age agreeing that they did more Easter-related activities this year. As a result, retailers promoted various activities to encourage participation in...
-
Sector Analysis
NewAmericas Fibercos and Towercos Market Dynamics and Opportunities
Americas Fibercos and Towercos Market Report Overview Fibercos and towercos achieve long-term contracts with landowners and telcos, providing stability for network operations. Building on this, towercos and fibercos can develop durable relationships with anchor clients thereby providing additional safety for investors. Telcos can combine their fiber rollouts in a JV fiberco to drive maximized coverage through shared rollouts, funding, and costs. This can also be beneficial in areas where the return on investment (ROI) on fiber can be lower for...
-
Sector Analysis
NewCell and Gene Therapies in CNS Disorders – Disease Overview, Treatment Options and Future Market Assessment
Reasons to buy the ‘Cell and Gene Therapies in CNS Disorders’ report: The report covers the global scope of drug development focusing mainly on the 8MM including the US, 5EU, Japan, and South Korea. The report focuses on the marketed CGT assets addressing CNS disorders as well as the top five CNS disorders with the most CGT pipeline assets. The report throws light on the competitive landscape of leading CGT agents in CNS Disorders including launch date projections, analyst consensus...
-
Sector Analysis
NewUnited Kingdom (UK) Easter Intentions and Consumer Spending Preferences, 2024 Update
The GlobalData Retail Easter intentions 2024 report forms part of the Retail Occasions series, and offers a comprehensive overview of the retail occasion of Easter, analysing consumers intentions for spending, gifting and celebrating.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ORM-5029 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ORM-5029 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ORM-5029 in Ovarian Cancer Drug Details: ORM-5029 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ORM-5029 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ORM-5029 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ORM-5029 in Colorectal Cancer Drug Details: ORM-5029 is under development for...